ArticleACS pharmacology & translational science2026
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved Drugs.
Rebecca Racz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.